7 magg 2020 anni - RCT (Preprint) - HCQ in patients with
mild to moderate COVID–19
Descrizione:
"The results of our trial did not show additional benefits of virus elimination by adding HCQ to the current SOC in patients mainly with persistent mild to moderate COVID–19." [26]
Aggiunto al nastro di tempo:
Data: